Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian R Poxton

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Journal of Medical Microbiology|March 7, 2003
Changes in sensitivity patterns to selected antibiotics in Clostridium difficile in geriatric in-patients over an 18-month periodLisa J Drummond, Jodie McCoubrey, David G E Smith, et al.
Journal of Medical Microbiology|May 16, 2008
Systemic antibody response to Clostridium difficile in colonized patients with and without symptoms and matched controlsKarla Sánchez-Hurtado, Maria Corretge, Esvet Mutlu, et al.
Journal of Medical Microbiology|January 22, 2011
A proposed nomenclature for cell wall proteins of Clostridium difficileRobert P Fagan, Claire Janoir, Anne Collignon, et al.
Immunology Letters|June 13, 2006
"Dirty little secrets"--endotoxin contamination of recombinant proteinsSonia J Wakelin, Ian Sabroe, Christopher D Gregory, et al.
Anaerobe|December 18, 2019
Bezlotoxumab for prevention of Clostridium difficile infection recurrence: Distinguishing relapse from reinfection with whole genome sequencingZhen Zeng, Hailong Zhao, Mary Beth Dorr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2019
Effect of Endogenous Clostridioides difficile Toxin Antibodies on Recurrence of C. difficile InfectionCiarán P Kelly, Ian R Poxton, Judong Shen, et al.
The Journal of Infectious Diseases|May 7, 2002
Proinflammatory responses to lipo-oligosaccharide of Neisseria meningitidis immunotype strains in relation to virulence and diseaseJan M Braun, Caroline C Blackwell, Ian R Poxton, et al.
Journal of Medical Microbiology|May 16, 2008
Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in EuropePatrizia Spigaglia, Fabrizio Barbanti, Paola Mastrantonio, et al.
BMC Microbiology|June 29, 2014
International Clostridium difficile animal strain collection and large diversity of animal associated strainsSandra Janezic, Valerija Zidaric, Bart Pardon, et al.
The New England Journal of Medicine|January 26, 2017
Bezlotoxumab for Prevention of Recurrent Clostridium difficile InfectionMark H Wilcox, Dale N Gerding, Ian R Poxton, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Medical Microbiology|March 7, 2003
Changes in sensitivity patterns to selected antibiotics in Clostridium difficile in geriatric in-patients over an 18-month periodLisa J Drummond, Jodie McCoubrey, David G E Smith, et al.
Journal of Medical Microbiology|May 16, 2008
Systemic antibody response to Clostridium difficile in colonized patients with and without symptoms and matched controlsKarla Sánchez-Hurtado, Maria Corretge, Esvet Mutlu, et al.
Journal of Medical Microbiology|January 22, 2011
A proposed nomenclature for cell wall proteins of Clostridium difficileRobert P Fagan, Claire Janoir, Anne Collignon, et al.
Immunology Letters|June 13, 2006
"Dirty little secrets"--endotoxin contamination of recombinant proteinsSonia J Wakelin, Ian Sabroe, Christopher D Gregory, et al.
Anaerobe|December 18, 2019
Bezlotoxumab for prevention of Clostridium difficile infection recurrence: Distinguishing relapse from reinfection with whole genome sequencingZhen Zeng, Hailong Zhao, Mary Beth Dorr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2019
Effect of Endogenous Clostridioides difficile Toxin Antibodies on Recurrence of C. difficile InfectionCiarán P Kelly, Ian R Poxton, Judong Shen, et al.
The Journal of Infectious Diseases|May 7, 2002
Proinflammatory responses to lipo-oligosaccharide of Neisseria meningitidis immunotype strains in relation to virulence and diseaseJan M Braun, Caroline C Blackwell, Ian R Poxton, et al.
Journal of Medical Microbiology|May 16, 2008
Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in EuropePatrizia Spigaglia, Fabrizio Barbanti, Paola Mastrantonio, et al.
BMC Microbiology|June 29, 2014
International Clostridium difficile animal strain collection and large diversity of animal associated strainsSandra Janezic, Valerija Zidaric, Bart Pardon, et al.
The New England Journal of Medicine|January 26, 2017
Bezlotoxumab for Prevention of Recurrent Clostridium difficile InfectionMark H Wilcox, Dale N Gerding, Ian R Poxton, et al.
Pageof 4